China Pioneer Pharma (CRPNF) 0.8654 $CRPNF
China Pioneer Pharma Joins Hand with NovaBay Pharmaceuticals and the NNFF To Offer Free New Life-Saving Treatment for "Flesh-Eating" Disease
JCN Newswire - Tue Dec 16, 5:51AM CST
China Pioneer Pharma Holdings Limited announces that, as the exclusive marketer, promotor and distributor for skin and wound cleanser NeutroPhase in mainland China and parts of Southeast Asia, the Group will offer the life- and limb-saving product, NeutroPhase, and relevant medical guidance at no charge to patients who suffer from flesh-eating disease in the region to tie in with the agreement signed between the product manufacturer - NovaBay Pharmaceuticals, Inc. and the National Necrotizing Fasciitis Foundation (NNFF) in the United States. This will enable doctors to save life of patients as quick as possible--- and to curb the deterioration of the situation to avoid the need for amputation.
China Pioneer Pharma was Granted Exclusive Importation, Sales and Co-Promotion Rights in Respect of Neoton
JCN Newswire - Tue Dec 02, 6:46AM CST
China Pioneer Pharma Holdings Limited announced that the Group through its wholly-owned subsidiary signed an agreement, with its important long-term partner Alfa Wassermann S.p.A of Italy for its product of creatine phosphate sodium for injection ("Neoton"
on 2 December, 2014. According to the Agreement, the Group through its wholly-owned subsidiary was granted by Alfa Wassermann the exclusive importation, sales and co-promotion rights of Neoton in the People's Republic of China (excluding Hong Kong, Macao Special Administrative Region and Taiwan). The term of the Agreement shall start from today until 31 December, 2019.
The Launch of JUTURNA-vq PTA Balloon Dilatation Catheter Approved in Singapore; China Pioneer Pharma is the Exclusive Distributor
JCN Newswire - Sun Nov 30, 6:07PM CST
China Pioneer Pharma Holdings Limited announced recently that Singapore's Health Sciences Authority(HSA) has approved the launch of JUTURNA-vq PTA Balloon Dilatation Catheter in Singapore on 24th November, which is the medical device produced by QualiMed Innovative MedizinprodukteGmbh (QualiMed). The Company is the exclusive distributor of JUTURNA-vq PTA Balloon Dilatation Catheter This medical device product has previously been approved for sale throughout Hong Kong, Thailand and Vietnam. China Pioneer Pharma owns about 24.4% shares of Q3 Medical Devices Limited, which is the holding company of QualiMed. The Company is also the exclusive distributor of QualiMed's medical products for vascular disease treatment in mainland China and throughout Southeast Asia.
China Pioneer Pharma Expands NeutroPhase Marketing in Taiwan
JCN Newswire - Tue Nov 04, 6:40PM CST
China Pioneer Pharma Holdings Limited, the leading comprehensive marketing, promotion and channel management service providers dedicated to imported pharmaceutical products and medical devices in China, today announced Taiwan's Food and Drug Administration has approved the launch of NovaBay Pharmaceuticals, Inc.'s medical devices product NeutroPhase Skin and Wound Cleanser for sale in Taiwan. China Pioneer Pharma will launch NeutroPhase in Taiwan in early 2015. NeutroPhase previously has been approved for sale throughout mainland China, Singapore, Malaysia and the United States. China Pioneer Pharma owns about 15% of NovaBay's shares, making it NovaBay's largest shareholder, and is also the exclusive distributor for NeutroPhase in mainland China and throughout Southeast Asia.
China Pioneer Pharma Joins Hand with NovaBay Pharmaceuticals and the NNFF To Offer Free New Life-Saving Treatment for "Flesh-Eating" Disease
JCN Newswire - Tue Dec 16, 5:51AM CST
China Pioneer Pharma Holdings Limited announces that, as the exclusive marketer, promotor and distributor for skin and wound cleanser NeutroPhase in mainland China and parts of Southeast Asia, the Group will offer the life- and limb-saving product, NeutroPhase, and relevant medical guidance at no charge to patients who suffer from flesh-eating disease in the region to tie in with the agreement signed between the product manufacturer - NovaBay Pharmaceuticals, Inc. and the National Necrotizing Fasciitis Foundation (NNFF) in the United States. This will enable doctors to save life of patients as quick as possible--- and to curb the deterioration of the situation to avoid the need for amputation.
China Pioneer Pharma was Granted Exclusive Importation, Sales and Co-Promotion Rights in Respect of Neoton
JCN Newswire - Tue Dec 02, 6:46AM CST
China Pioneer Pharma Holdings Limited announced that the Group through its wholly-owned subsidiary signed an agreement, with its important long-term partner Alfa Wassermann S.p.A of Italy for its product of creatine phosphate sodium for injection ("Neoton"
on 2 December, 2014. According to the Agreement, the Group through its wholly-owned subsidiary was granted by Alfa Wassermann the exclusive importation, sales and co-promotion rights of Neoton in the People's Republic of China (excluding Hong Kong, Macao Special Administrative Region and Taiwan). The term of the Agreement shall start from today until 31 December, 2019. The Launch of JUTURNA-vq PTA Balloon Dilatation Catheter Approved in Singapore; China Pioneer Pharma is the Exclusive Distributor
JCN Newswire - Sun Nov 30, 6:07PM CST
China Pioneer Pharma Holdings Limited announced recently that Singapore's Health Sciences Authority(HSA) has approved the launch of JUTURNA-vq PTA Balloon Dilatation Catheter in Singapore on 24th November, which is the medical device produced by QualiMed Innovative MedizinprodukteGmbh (QualiMed). The Company is the exclusive distributor of JUTURNA-vq PTA Balloon Dilatation Catheter This medical device product has previously been approved for sale throughout Hong Kong, Thailand and Vietnam. China Pioneer Pharma owns about 24.4% shares of Q3 Medical Devices Limited, which is the holding company of QualiMed. The Company is also the exclusive distributor of QualiMed's medical products for vascular disease treatment in mainland China and throughout Southeast Asia.
China Pioneer Pharma Expands NeutroPhase Marketing in Taiwan
JCN Newswire - Tue Nov 04, 6:40PM CST
China Pioneer Pharma Holdings Limited, the leading comprehensive marketing, promotion and channel management service providers dedicated to imported pharmaceutical products and medical devices in China, today announced Taiwan's Food and Drug Administration has approved the launch of NovaBay Pharmaceuticals, Inc.'s medical devices product NeutroPhase Skin and Wound Cleanser for sale in Taiwan. China Pioneer Pharma will launch NeutroPhase in Taiwan in early 2015. NeutroPhase previously has been approved for sale throughout mainland China, Singapore, Malaysia and the United States. China Pioneer Pharma owns about 15% of NovaBay's shares, making it NovaBay's largest shareholder, and is also the exclusive distributor for NeutroPhase in mainland China and throughout Southeast Asia.
